Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.90K | 37.90K | 1.86M | 2.48M | 3.10M |
| Total Other Revenue | 8.21M | 7.42M | 6.83M | 6.31M | 5.74M |
| Total Revenue | 8.25M | 7.46M | 6.87M | 6.96M | 7.02M |
| Cost of Revenue | 40.00M | 38.14M | 37.09M | 34.58M | 31.85M |
| Gross Profit | -31.75M | -30.68M | -30.21M | -27.62M | -24.82M |
| SG&A Expenses | 7.61M | 7.91M | 8.39M | 8.70M | 8.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.10K | 8.30K | -33.30K | -52.70K | -73.40K |
| Total Operating Expenses | 47.65M | 46.06M | 45.45M | 43.23M | 40.75M |
| Operating Income | -39.40M | -38.60M | -38.57M | -36.26M | -33.72M |
| Income Before Tax | -40.03M | -37.96M | -36.75M | -30.89M | -24.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.03 | -37.96 | -36.75 | -30.89 | -24.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.03M | -37.96M | -36.75M | -30.89M | -24.78M |
| EBIT | -39.40M | -38.60M | -38.57M | -36.26M | -33.72M |
| EBITDA | -37.69M | -36.93M | -36.92M | -34.69M | -32.23M |
| EPS Basic | -0.30 | -0.31 | -0.32 | -0.28 | -0.25 |
| Normalized Basic EPS | -0.19 | -0.19 | -0.20 | -0.18 | -0.15 |
| EPS Diluted | -0.31 | -0.31 | -0.32 | -0.28 | -0.25 |
| Normalized Diluted EPS | -0.19 | -0.19 | -0.20 | -0.18 | -0.15 |
| Average Basic Shares Outstanding | 529.78M | 498.22M | 466.67M | 435.67M | 404.68M |
| Average Diluted Shares Outstanding | 529.78M | 498.22M | 466.67M | 435.67M | 404.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |